Coronavirus Response Newsletter

This post has been archived and contains information that may be out of date.

Administration of Johnson & Johnson Vaccine Resumes

On April 23, the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and CDC’s Advisory Committee on Immunization Practices recommended resuming administration of the Johnson & Johnson (aka Janssen or J&J) vaccine.

On April 24, the Western States Scientific Review Advisory Committee also recommended resuming the J&J vaccine. In response, the California Department of Public Health (CDPH) issued a statement on April 24 stating, “Clinics in California may begin administering the Johnson & Johnson vaccine immediately as long as they provide appropriate educational materials to inform patients of the vaccine’s low risk of associated health effects and other available vaccine options.”

To assist health care providers administering the J&J vaccine, the FDA has issued an updated fact sheet.

Next CDPH Office Hours: April 30

CDPH will hold a COVID-19 Vaccination Office Hours webinar for hospitals on April 30 from 9 to 10 a.m. (PT). To participate, visit this link.

Next CDPH Call for Health Care Facilities: May 4, 8-9 a.m. (PT)  

Dial: (844) 721-7239  
Passcode: 7993227 

Summary of April 13 CDPH Call

CDPH has provided a summary of its April 13 call with health care facilities. The department has also issued an update to the summary of its April 6 call.

Media Coverage

In case you missed them, here are some recent stories of interest:

Data Resources

  • State Resources: Monitor ICU capacity by region or by county.
  • CHA Resources: Hospitals can access county dashboards through the CHA COVID-19 Tracking Tool, which includes hospital-specific data on ICU capacity.